Privia Health Group, Inc. reiterated earnings guidance for the year 2024. For the period, the company expects GAAP revenue of $1,600 million to $1,675 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.03 USD | +3.34% | +1.55% | -26.01% |
05-30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
05-20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.01% | 1.97B | |
+26.12% | 89.18B | |
-26.52% | 76.11B | |
+1.62% | 27.11B | |
-10.35% | 17.13B | |
-0.36% | 16.83B | |
+1.04% | 15.4B | |
+77.12% | 13.68B | |
+79.12% | 13.25B | |
-25.79% | 12.83B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group, Inc. Reiterates Earnings Guidance for the Year 2024